Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-007118-12Phase 2Active
Phase 2 trial of metformin in obesity and insulin resistance (IR), sponsored by Emilio Garcia Garcia. Primary endpoints: Efficacy of metformin in obese non-diabetic children with insulin resistance, Safety of metformin and 1 more. Started Mar 2008; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-007118-12.